The Use of Mebendazole in COVID-19 Patients: An Observational Retrospective Single Center Study
The Use of Mebendazole in COVID-19 Patients: An Observational Retrospective Single Center Study
About this item
Full title
Author / Creator
Publisher
New York: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
New York: Hindawi
Subjects
More information
Scope and Contents
Contents
Background. An in-silico screen identified mebendazole with potential antiviral activity that could be a repurposed drug against SARS-CoV-2. Mebendazole is a well-tolerated and cheap antihelminthic agent that is readily available worldwide and thus could be a therapeutic tool in the fight against COVID-19. Methods. This is an observational retrospe...
Alternative Titles
Full title
The Use of Mebendazole in COVID-19 Patients: An Observational Retrospective Single Center Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5bf3e47fd7564dd8a6698a48ab0428b7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5bf3e47fd7564dd8a6698a48ab0428b7
Other Identifiers
ISSN
1687-8639
E-ISSN
1687-8647
DOI
10.1155/2022/3014686
